Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of Flucloxacillin Absorption and %time/MIC using the Flucloxacillin absorption test
2019-003933-40Phase 4Active
- Sponsor
- Haaglanden Medical Centre
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of flucloxacillin in Staphylococcal bacteremia, sponsored by Haaglanden Medical Centre. Primary endpoint: Prediction of time above MIC using 3-point and 7-point concentration curves before and after switch to oral flucloxacillin. Started Jan 2020; status: active.
02
Drugs
flucloxacillin
03
Conditions
Staphylococcal bacteremia
Beyond the preview
Go deeper on 2019-003933-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003933-40.